Trial record 1 of 3 for:    Study of the Efficacy and Safety of Bardoxolone Methyl in Patients
Previous Study | Return to List | Next Study

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02657356
Recruitment Status : Recruiting
First Posted : January 15, 2016
Last Update Posted : September 24, 2018
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2020
  Estimated Study Completion Date : June 2020